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Although the literature reports a higher incidence of anxiety disorders in women, the majority of basic research has focused on
male rodents, thus resulting in a lack of knowledge on the neurobiology of anxiety in females. Bridging this gap is crucial for
the design of effective translational interventions in women. One of the key brain mechanisms likely to regulate anxious behavior
is adult hippocampal neurogenesis (AHN). This review paper aims to discuss the evidence on the differences between male and
female rodents with regard to anxiety-related behavior and physiology, with a special focus on AHN. The differences between
male and female physiologies are greatly influenced by hormonal differences. Gonadal hormones and their fluctuations during the
estrous cycle have often been identified as agents responsible for sexual dimorphism in behavior and AHN. During sexual maturity,
hormone levels fluctuate cyclically in females more than in males, increasing the stress response and the susceptibility to anxiety. It
is therefore of great importance that future research investigates anxiety and other neurophysiological aspects in the female model,
so that results can be more accurately applicable to the female population.
Dedicated to the memory of Dr. Anna Claudia Domingos da Silveira da Luz, whose efforts and dedication will always be a
legacy for our lab
1. Introduction
Anxiety and fear are adaptive emotional reactions to both
innate and conditioned stimuli perceived as dangerous. They
have likely been conserved throughout evolution for their
adaptive value in the survival of species by warning the
individual of potential dangers through the triggering of
a series of neurochemical, neuroendocrine, and behavioral
responses. However, when these reactions become constant
and intense, with prolonged or inadequate responses to
neutral stimuli or even in the absence of stressors, it may be
indicative of pathological anxiety [1, 2].
Anxiety disorders cause great suffering and loss of quality
of life [3, 4]. A substantial literature suggests that women
may be more vulnerable than men to developing anxiety [3–
6]. Anxiety disorders are diagnosed at least twice as often in
women than in men, and the prevalence in women increases
with age, with the gradual decline of estrogen E2 secretion
from the ovaries at menopause [7, 8]. Generalized anxiety
disorder (GAD), for example, occurs in approximately 5%
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Figure 1: AHN is important for cognitive and emotional learning. The newly born neurons continuously generated in the postnatal
hippocampus are believed to regulate cognitive and emotional tasks, as occurs in the contextual fear learning paradigm and the spatial
learning assessed in theMWM. In contextual fear learning, the hippocampus is thought to be essential for the association between a previously
neutral context and an aversive stimulus (in this case, a mild footshock) leading to a fear response (conditioned freezing) when the individual
is reexposed to the context where the fear learning occurred. In the case of spatial learning, as assessed by the MWM, hippocampal cells are
believed to play an important role in the cued spatial navigation strategies that make it possible for the rodent to more quickly find the hidden
platform across the test trials. AHN = adult hippocampal neurogenesis; MWM =Morris water maze.
of the population; however, the incidence doubles in post-
menopausal women [9].
At the neurobiological level, the basis of anxiety can be
conceived of as a disruption in the fundamental mechanism
of fight and flight responses regulated by the hypothalamic-
pituitary-adrenal (HPA) axis. Fear and anxiety, therefore,
involve brain structures participating in the regulation of the
HPA axis, such as the amygdala, the hypothalamus, the peri-
aqueductal grey, and the hippocampus [10]. Here, we high-
light this latter structure and its remarkable ability to generate
newly functional neurons throughout life, a phenomenon
called adult hippocampal neurogenesis (AHN). Besides their
well-known functions in regulating cognitive processes, these
newly generated neurons have also been implicated in the
regulation of fear and anxiety [11, 12] (Figure 1).
In addition, evidence suggests that both progesterone [13]
and estrogens [14, 15] play an important role in enhancing
the proliferation and survival of new neurons in the hip-
pocampus of adult females, with ovariectomized (OVX) rats
displaying impaired AHN [16]. Estrogens, particularly E2,
play an important role in brain development, functioning,
and aging; in addition, they exert important antioxidant [17],
anxiolytic, and antidepressant-like effects [9, 18–20] besides
modulating the dopaminergic [21, 22], serotonergic [23],
and cholinergic neurotransmitter systems [24]. The cyclical
nature of the secretion of estrogen until menopause, when
women experience its almost total withdrawal, supports the
role of hormones in gender differences and may contribute
to the greater vulnerability of women to anxiety disorders at
this age. However, in animal models, both at the behavioral
and at the neurogenic levels males and females may respond
differently, depending on the treatment, age, or exposure
to stressors used, as will be seen in this review. This leads
to a lack of a clear understanding on whether males and
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The estrous cycle consists of the reproductive cycle of females. It lasts four to five days
and is divided into four phases: proestrus, estrous, metaestrus, and diestrus [103]. It can be
identified by cytological analysis according to the proportion and cell types in the
vaginal secretion [104].
Each phase of the cycle lasts around 24 hours and is mainly linked to fluctuations in
estradiol levels, which begins at puberty and ends in senescence (about 12 months in
female rats). The metaestrus and diestrus phases have low level concentrations of serum
estradiol. The proestrus is characterized by the highest level of estradiol followed by the
estrous phase, where levels of the hormone start to decrease, coinciding with ovulation
and corpus luteum formation [105].
Box 1: Estrous cycle.
females display different neurogenic profiles either at baseline
or under different experimental conditions. Such possible dif-
ferences in neurogenesis could account at least in part for the
differences in anxiety observed between genders in clinical
practice. Therefore, considering the importance of under-
standing gender differences in the context of anxiety, so that
more tailored interventionsmay be delineated for the women
population, it is essential to discuss the evidence on the
possible biological differences between males and females;
here, a special focus is given to AHN and anxious behavior.
2. Neurobiology of Anxiety: Differences
between Males and Females
Overall, women and men are physiologically very similar,
except for the time, pace, and schedule of the production and
secretion of certain hormones. Both genders are undifferen-
tiated until the sixth week of gestation, when the testicles
develop in males and the production of androgens begins,
while in females a substantial increase in follicle stimulating
hormones (FSH) takes place around 12 to 20 weeks. After this
period, this process of sexual differentiation is terminated,
and the hormonal environment of the brain is again very
similar in males and females until puberty [7].
Estrogen is a crucial hormone for the regular functioning
of the brain, and its exhaustion at menopause may contribute
to the higher probability of development of pathological anxi-
ety [25]. OVX ratmodels have beenwidely used to investigate
the effects of reduced estrogen levels at menopause, although
the fact that it induces a drastic decline in estrogen secretion,
whereas at menopause this process occurs gradually, is an
important limitation of themodel.The aged rodent is another
usefulmodel, but less used for this purpose. Aged femalemice
have very low levels of E2 and experience increased anxiety
that is associated with the decline in ovarian function [9].
Hormonal differences also play a role in levels of stress
markers. Females present elevated HPA axis markers at both
resting and stressed states [26], as well as higher baseline
plasma corticosterone (CORT) levels in comparison to males
[27]. In addition, greater CORT response has been demon-
strated in females thanmales in some anxiety tests such as the
elevated plus-maze (EPM) and the defensive prod-burying
test even after treatment with diazepam [28].
Additionally, CORT levels in females are influenced by
the estrous cycle peaking in the proestrus phase and declining
during the estrous phase, which at least partly explains why
males and females respond differently to stressful situations
[29] (for more details on the estrous cycle, please see Box 1).
Although clearly important, the influence of sex hor-
mones is not the only mechanism involved in the develop-
ment of sexual dimorphism. Genetic mechanisms, regardless
of hormone action, may trigger the sexual differentiation of
the brain and behavior [5]. The environment also appears to
have an important impact on the dimorphism and differenti-
ation of the central nervous system (CNS), thus also affecting
behavior [5, 30]. In addition, sex differences in AHN (as
will be later discussed) can also differently influence sexual
dimorphisms.
Growing evidence also points to a role of gastrointesti-
nal (GI) activity in leading to differential behavioral and
neuroendocrine changes in males and females. Research
data show that gastric inflammation induced by iodoac-
etamide (IAA) leads to anxiety behavior in female rats
by a neuroendocrine pathway (the HPA axis), but not in
male rats [27]. The reduction in circulating CORT, in the
mRNA expression of glucocorticoid receptors (GR), and the
increase in corticotrophin-releasing factor (CRF) mRNA in
the hypothalamus of IAA-treated females suggest that GI
activity has a gender impact on theHPAaxis, being associated
with its hyperactivity in females. This hyperactivity, in turn,
is likely due to different sensitivities in the negative feedback
of the HPA axis by CORT [27].
Gender differences were also found in the maternal sep-
aration model in rats, where separation during the lactation
period resulted in decreased anxiety in females in compar-
ison to males, despite the decreased expression of gamma-
aminobutyric acid- (GABA-) A receptors in both sexes [31].
Significant gender differences were also reported in the
prelimbic (PL) cortex activity during fear extinction and
extinction recall [32]. Males presented PL activity decreased
in the safe context, while females displayed increased PL
activity in the same context; however, both showed increased
infralimbic (IL) cortex activity before extinction recall com-
pared to before extinction. These results suggest that female
rats show increased expression of learned fear involving the
persistent activation of PL.
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According to the authors, this result may be related
to possible disruptions in hippocampal connectivity to the
PL, considering the role of the hippocampus in mediat-
ing contextual processing. In particular, the input of the
ventral hippocampus (VH) to PL appears to be linked to
the regulation of the extinction process [33]. In this sense,
it has been shown that the temporary inactivation of the
VH increases PL activity and expression of learned fear
after extinction [34]. The authors highlight that females
could therefore display changes in hippocampal-mediated
inhibition of mPFC function, in agreement with findings in
female patients with posttraumatic stress disorder (PTSD)
[32, 35]. Furthermore, anxiety has been linked with impaired
hippocampal neurogenesis [12], raising the possibility that
altered AHN could also participate in the regulation of the
fear circuitry. Whether this could be related to differential
rates of AHN between males and females is a question that
will be further discussed next.
2.1. AdultHippocampalNeurogenesis andAnxiety. Adult neu-
rogenesis, a phenomenon first described by Altman during
the 60s [36], refers to a mechanism of continuous formation
of newly functional neurons throughout life, a process that
takes place only in specific regions of the adult brain [37].
In this regard, although also identified in structures such
as the hypothalamus and the amygdala [38], neurogenic
niches in the adult brain are mainly considered to reside
in the dentate gyrus (DG) of the hippocampus and the
subventricular zone (SVZ) adjacent to the lateral ventricles
[39, 40].
Due to its influence on mental health-related behaviors,
including anxiety, we will focus this review on hippocampal
neurogenesis.
The hippocampus is a region extremely sensitive to stress,
and neurogenesis has been proposed to be linked to the
development of pathological anxiety [41]. Growing evidence
supports this idea, as chronic stress has been shown to reduce
hippocampal neurogenesis, besides changing the activity
of the HPA axis, thereby undermining the ability of the
hippocampus to modulate the brain areas involved in stress
and anxiety responses [42, 43].
AHN is a dynamic and highly regulated process, com-
prised of the stages of proliferation, differentiation, migra-
tion, integration, and survival [37, 40]. The subgranular zone
(SGZ) of the DG is known to contain a large number of
neural progenitor cells (NPCs) that retain the ability to divide
resulting in cells that have the potential to become mature
granule cells [44]. Proliferation is an expansion of the pool
of NPCs, followed by a selection process where about half
of these new cells will undergo apoptosis [45], while the
surviving neuroblasts migrate into the granular zone of the
DG [46]. Mice studies have shown that around four weeks
these new cells already begin to express neuronalmarkers and
are functionally incorporated into the preexisting circuit [47].
This mechanism of generation of new neurons can be
affected by external stimuli, such as learning and memory
[48], exercise [49], diet [50], environment [51], stress [52], and
aging [53], aswell as pharmacological agents [54] and internal
stimuli. Among the internal stimuli known to upregulate
the AHN process, we can highlight the microenvironmental
factors, such as trophic factors [55], growth factors [56],
increased vasculature [48], chemical and electrical changes
such as excitatory stimuli [57, 58], and gonadal hormones
(estradiol in females and testosterone in males) [59]. More-
over, there are also microenvironmental factors that nega-
tively regulate this process, such as immune responses [60],
glucocorticoids [42], and physiological changes associated
with aging [61].
In addition, recent studies have attributed to AHN a reg-
ulatory role in various cognitive processes such as memory
[42, 62], learning [61, 63, 64], besides a significant influence
on affective disorders [65], anxiety [12], and emotional
behavior [66]. Evidence for the role of AHN in the regulation
of learning and memory is based on electrophysiological
findings showing that new neurons in the hippocampus
exhibit enhanced long-term potentiation (LTP), an impor-
tant cellular mechanism underlying learning processes and
memory [67]. In accordance with this, studies have shown
that ablation of neurogenesis using genetic manipulation or
irradiation techniques results in behavioral changes, such
as cognitive deficits [68], including impaired performance
acquired in the water maze by runners mice [69].
Despite the classic role attributed to the hippocampus and
AHN on cognition, several researchers have suggested a link
between neurogenesis and anxiety-related behaviors. One of
the most convincing studies demonstrating this association
was published by Revest et al. [12]. In this study, the authors
used an inducible transgenic strategy that enabled the specific
ablation of newborn neurons in the adult DG to demonstrate
that deficits in hippocampal neurogenesis lead to an increase
in anxious behavior. Furthermore, Dias and colleagues have
found a decreased number of immature neurons in the DG
of a rodent model for the study of generalized anxiety [70]. In
addition, it has been suggested that the birth of new neurons
in the hippocampus may be involved in the ability of the DG
to distinguish contexts, and deficits in this ability could be
an important factor in the etiology of anxiety disorders [11,
71].The promotion of AHN has therefore been discussed as a
potential target for the treatment of anxiety disorders [65, 71,
72].
2.2. Adult Hippocampal Neurogenesis: Differences between
Males and Females. The differences between sexes with
regard to AHN are derived largely from the singular phys-
iology of females that allows pregnancy, parturition, and
lactation [73]. This particular physiology makes females
undergo profound hormonal changes throughout life. In
addition, hormonal fluctuations experienced by females dur-
ing biological processes such as the estrous cycle, pregnancy,
andmaternity are associated with a number of changes in the
brain and behavior [74].
Gonadal hormones, besides exerting a powerful anxi-
olytic role, are also known by their effects in directly affecting
hippocampal neurogenesis in females, via regulation of the
proliferation and survival of new neurons [59]. This effect
is possible due to the presence of estrogen receptors, ER𝛽
and ER𝛼 in the DG [59, 75]. Evidence has shown that both
ER𝛼 and ER𝛽 receptors are involved in the improvement
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of AHN in rats [26, 76]. However, ER𝛽 agonists result in
a greater neurogenic response, suggesting that ER𝛽 may
be more strongly associated with AHN than ER𝛼 [75].
Conversely, the ER antagonist ICI 182,780 could partially
block the rise in estradiol-induced cell proliferation in the
DG of rats [38]. Luteinizing hormone (LH), known for
its important role during pregnancy and sexual behavior,
also exerts influence on neurogenesis in females. Studies
have shown that exposure of females to male pheromone or
subcutaneous administration of a high dose of LH induced
increased proliferation of new neurons both in the SVZ and
in the DG [77]. Induced sexual experience was also reported
to increase neurogenesis and reduce anxiety in females [78].
Although other female gonadal hormones like proges-
terone [73, 79] and LH [77] can also lead to improvements
in AHN, estrogens are the most widely studied class of
gonadal hormones, especially estradiol, themost potent form
of estrogen [75]. Several articles have shown significant
increases in the proliferation and survival of newly born
neurons in the hippocampus after treatment with estradiol
[13, 59, 73, 76, 80, 81], but not with other estrogens, such
as estrone [14, 75]. In addition, during the proestrus phase
of the estrous cycle, where estradiol levels are higher, rats
exhibit about 50% higher proliferation than rats during
diestrus and estrus stages when estradiol is low [82]. In OVX
rats, proliferation of new neurons is significantly reduced,
while estrogen replacement reverses the effect of ovariectomy
[38, 83]. Additionally, another study has shown increased
proliferation of new DG cells in OVX rats after estradiol
injection or addition of soy extract in drinking water [84].
Furthermore, estrogen can also mediate AHN via growth
factors and/or neurotransmitter systems.
Evidence suggests that estrogen regulates the expression
of BDNF which in turn promotes the survival of newborn
neurons in the hippocampus [85]. Moreover, it is known that
estrogen plays an important role in modulating the levels
of serotonin (5-hydroxytryptamine; 5-HT) synthesis via the
regulation of tryptophan hydroxylase [74]. It has been shown
that an increase in 5-HT in theDG increases cell proliferation
while a reduction of 5-HT reduces proliferative activity [38].
In addition, serotonin antagonists can block the effect of
estradiol to enhance cell proliferation [59, 86]. Also, it is well
established that animal models of anxiety have exaggerated
HPA axis responses to stress. In this context, it has been
shown that E2 administration to rats with low endogenous
levels of this hormone can alter this response, but its effects
are previous experience- and regimen-dependent [9].
Estrogen levels have, therefore, been positively correlated
with cell proliferation and negatively correlated with cell
death [83]. During pregnancy and postpartum period, for
example, estrogen is related with an increase of neuroplastic-
ity [83]. During the proestrus phase, which is characterized
by high levels of circulating estrogen, females exhibit greater
cell proliferation in the DG thanmales, or females during the
other phases of the estrous cycle [87, 88]. Moreover, several
studies have shown that females and males respond differ-
ently to gonadal hormones administration in the context of
hippocampal neurogenesis (see Table 1).
Treatment with estradiol or estradiol benzoate produced
different behavioral effects in both genders [80, 89]. With
regard to neurogenesis, females after estradiol benzoate
treatment exhibited an increase in cell proliferation, and a
decrease in both overall cell death and neuron survival in
the DG, but males are minimally affected [80]. On the other
hand, males injected with estradiol for 30 days presented
no change in neurogenesis; however, they showed significant
increased AHN via cell survival after treatment with both
testosterone and dihydrotestosterone (DHT), one of themain
metabolites of testosterone [90]. In addition, rats treated with
the organochlorine insecticide methoxychlor (MXC), a syn-
thetic compound known for their xenoestrogens properties
able to cause disruption of the endocrine system, exhibited
higher density of surviving cells inmales than in females [91].
Sex differences in regard to AHN with respect to the
stress response have also been widely reported. Exposure to
stress increases levels of glucocorticoids, and when occurring
during the prenatal period, this increase can cause substantial
changes in neuroplasticity, reducing the capacity for cell
proliferation in adults [92]. Accordingly, analysis of the brain
tissue of adult rats whose dams were subjected to restraint
stress 3 times per day during the last 10 days of pregnancy
showed decreased survival of new neurons in the DG and
increases of hippocampal BDNF levels in males, but not in
females [93]. Besides, the type of stress and the duration
(whether acute or chronic) are also an important factor in
influencingAHN. Both acute stress caused by foot-shock [94]
as caused by acute exposure to a predator odor have been
reported to be associated with reduced cell proliferation in
themale, but not in the female hippocampus [95]. Conversely,
individually housed female rats which underwent chronic
stress (daily foot-shocks for 3 weeks) showed increased BrdU
labeling in comparison to males [82].
The age of animals is another relevant variable for the
understanding of gender differences in the context of AHN.
Postnatal neurogenesis during puberty occurs in young ani-
mals (between postnatal days (PND) 21 and 28; PND21–28)
who have not yet reached sexual maturity [96]. Investigations
of neurogenesis at this stage of development are important for
the understanding of themechanisms underlying neurogene-
sis and evaluation of their possible changes and particularities
throughout life. Hodes et al. compared the effects of chronic
fluoxetine treatment in adult and peripubescent rats of both
sexes and found an increase in cell proliferation in adultmales
but not in adolescent males or females, as well as reduced
cell survival in females but not in males [97]. Investigations
about the effects of maternal deprivation in rats in early
life reported increased proliferation in the DG in males and
decreased in females at PND21 [98]. However, in an experi-
ment in which male mice were subjected to early life stress
(maternal separation) it was found that rats tested during
peripubescence (PND21) exhibited increased neurogenesis,
whereas when tested during adulthood (2 months old) no
differences were found, and at middle-age (15 months old)
AHN was decreased [99]. Moreover, using a different type of
early life stressor (limited nesting and bedding material from
PND2–9), Naninck and colleagues showed that both sexes
exhibited significantly increased proliferation at PND9, but
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Table 1: Differences between males and females with regard to AHN.
Model Intervention/behavioralparadigm
Differences in AHN
between males and females
Differences in anxious
behavior between
males and females
Differences in other types
of behavior between
males and females
Reference
PND70–90
Sprague-Dawley rats Eyeblink conditioning
Twice more new cells
(mainly neuroblasts)
survived in the female
than in the male
hippocampus
—
Females learned to time
the conditioned response
faster than males
[63]
380 g (male) and
240 g (female)
Wistar rats
Exposure to stressors
↑ proliferation in the DG
of females compared to
males; ↑ DCX in the DG of
males compared to females
—
Females showed ↑ basal
and stress-induced HPA
axis activity compared to
males
[87]
PND80–90
Sprague-Dawley rats
Treatment with E2 or
sesame oil
↑ proliferation, ↓ cell
death, and ↓ survival in
the DG of females; males
were affected minimally
—
Female rats froze less
than males after
contextual fear
conditioning
[106]
PND80–90
Sprague-Dawley rats
Treatment with E2
benzoate
↓ survival, ↑ proliferation,
↓ cell death in the DG of
females, and no effect in
males
— — [80]
3-month-old Wistar
rats Chronic stress
↓ BrdU labelling in males,
but ↑ in females — —
[82]
250–300 g
Sprague-Dawley rats
Acute stress (exposure
to a predator odor)
↓ proliferation, ↓ cell death
in males but not in females — —
[95]
PND58–62
Sprague-Dawley rats Spatial task
↑ BrdU-labeled cells in
males, ↑ cell activation in
females but not in males
—
Males performed better
in the spatial but not cue
task than females
[107]
2-3-month-old
Sprague-Dawley rats Acute stress
↓ proliferation in male
hippocampus but not in
female
—
Exposure to stress
significantly ↓ learning
ability in females but ↑ in
males; males expressed
more helplessness
behavior than females
[94]
2-3-month-old Swiss
CD1 mice Treatment with MXC
↑ survival in males
compared to females
Male mice exhibited ↓
contextual conditioned
freezing compared to
females
[91]
3-month-old
Sprague-Dawley rats PRS
↓ number of new neurons
in the DG and ↑ BDNF
levels in males but not in
females
Males showed ↑
anxiety, while females
displayed ↓ anxiety in
the EPM
— [93]
PND63–65;
PND24–26
(peripubescent)
Sprague-Dawley rats
Fluoxetine treatment
↑ cell proliferation in
males but not in females
↓ cell survival in females
but not in males
— — [97]
C57Bl/6J mice
ES (limited
nesting/bedding
material)
↓ cell survival only in
males —
Males showed impaired
cognitive performance in
the ORT, OLT, and
MWM, compared to
females
[100]
AHN = adult hippocampal neurogenesis; BDNF = brain-derived neurotrophic factor; BrdU = bromodeoxyuridine; DG = dentate gyrus; DHT =
dihydrotestosterone; DCX = doublecortin; EPM = elevated plus maze; ES = early life stress; E2 = estradiol; MXC =methoxychlor (organochlorine insecticide);
PND = postnatal day; PRS = prenatal restraint stress; SVZ = subventricular zone; T = testosterone; ES = early life stress; ORT = object recognition task; OLT =
object location task; MWM =Morris water maze.
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in adulthood males presented reduced long-term survival of
newly generated cells, while females were not affected [100].
The effects of early life stress thus appear to be sex- and
age-dependent, with different responses depending on the
age at which the hippocampus is under analysis. Increased
neurogenesis in young rodents which were subject to early
stress may be explained as a compensatory mechanism
enabling the survival of the organism under adverse con-
ditions. However, this early improvement is not always
observed in females. In addition, it may be interesting to note
that the decreased neurogenesis reported in some studies in
females using early life stress occurs during a critical period
of brain development, which could increase the vulnerability
of females to the development of psychiatric disorders such
as depression [101], a condition often found to be comorbid
with anxiety. A reduction in hippocampal volume in women
who experienced early childhood trauma has been reported,
suggesting that stress early in life can alter the structure and
function of the hippocampus in humans also [102]. Whether
this reduced hippocampal volume is also associated with
reductions in AHN is a question yet to be investigated.
3. Potential Interventions for
the Enhancement of AHN and
Alleviation of Anxiety
Several external factors can induce physiological changes in
the organism, thus exerting influence over AHN rates [38,
108, 109]. Based on this knowledge, different interventions
have been proposed as possible enhancers of this mechanism
[9, 38, 45, 110]. Here, we highlight some of them as possible
ways to help overcome anxious symptoms, although it is clear
that further studies are needed in order not only to clarify the
participation of AHN as a pivotal mechanism underlying the
higher anxiety observed in the women population but also
to ascertain the effectiveness of these interventions among
females.
Exercise is cited as one of the most powerful stimulants
of neurogenesis [111–114]. It is believed that this effect is
due to the increased oxygenation, metabolism, and blood
flow favored by exercise, which could result in an increased
nutrient delivery, providing increased synthesis and release
of growth factors, such as brain-derived neurotrophic fac-
tor (BDNF), and neurotransmitters [115–117]. Furthermore,
physical exercise has been reported to reduce anxiety. Cor-
roborating this idea, studies have shown that voluntary
wheel running produced anxiolytic effects in rats and mice
[118–120], while the cessation of voluntary wheel running
increased anxiety and impacted AHN negatively [121]. This
strongly indicates that the improvement of neurogenesis
afforded by exercise is associated with reduced anxious
symptoms [121], although excessive physical exercise, at least
in male mice, has been shown to improve neurogenesis
but also anxiety-like behavior [122]. Furthermore, depending
on the context, voluntary exercise can accentuate anxiety
in females, as is the case with treatment with androgenic
anabolic steroids [123]. Further studies are therefore needed
in order to unravel the optimal conditions where females can
benefit from physical exercise as an intervention to reduce
anxiety.
Another factor with great positive impact over AHN
is diet. Dietary interventions can comprise nutrient con-
tent, quantity, frequency, and texture [50, 124, 125]. Caloric
restriction (CR), for instance, has been cited as an effective
intervention in the expansion of neurogenesis [50]. Studies
showed that CR rats displayed an increase inAHN rates when
compared to animals fed ad libitum [126]. In addition, CR
is also aimed to improve some cognitive processes generally
impaired in anxious patients, such as fear extinction learning
and retention [127]. As shown by Riddle and colleagues,
after CR treatment for 7 days, significant effects on the
enhancement of fear extinction and retention were found
only in females but not in male mice [127].
Also pointing for anxiolytic properties of CR, a study
showed that male rats under a 25%CR regimen enteredmore
in the open arms of the EPM and spent more time in the
center of the arena in the open-field test (OFT), indicating
reduced anxiety [128].
With respect to the frequency of food intake, studies in
rodents subjected to intermittent fasting (IF), where animals
are fed on alternate days, also showed improvement in
brain plasticity by increasing the survival of new neurons
generated [129] as well as improvement in the ability to
integrate and consolidate information compared to mice
fed ad libitum [130]. However, the literature still lacks data
on mechanisms underlying the effects of IF specifically in
females and its possible role in anxiety disorders. Further
studies are therefore required for a deeper understanding of
this intervention, especially in the female population.
With regard to the quality of nutrients, some of the
beneficial compounds more thoroughly investigated as brain
plasticity enhancers are the polyphenols and the n-3 polyun-
saturated acids (PUFA). Polyphenols (such as curcumin and
resveratrol) are bioactive compounds found in a number
of plants and spices present in the human diet, such as
turmeric (in the case of curcumin) and red berries, the skin
of red grapes, red wine, and nuts (in the case of resveratrol).
These compounds are known for their neuroprotective and
antioxidants actions [131] in addition to their anxiolytic
and antidepressant properties [110, 132]. The improvement
of AHN as a result of polyphenolic treatment has been
shown both in vitro and in vivo, with curcumin-treated mice
exhibiting increased cell differentiation [133].
OVX rat models have been used to investigate the pro-
tective role of grape powder on anxiety in estrogen-deficient
females. OVX rats treated with grape powder for 3 weeks
showed decreased anxiety [134]. In addition, a study in OVX
mice suggested that resveratrol could act as an ER agonist
mimicking the effects of estrogen [135], which potentially
could be used as a safe alternative to protect the brain against
the effects of estrogen deficits that occur in menopause.
As well as treatment with polyphenols, the consumption
of foods rich in PUFAs has also been shown to exert positive
effects on neurogenesis. A study by Venna et al. found an
increase in cell proliferation in the DG after 5 and 6 weeks
of PUFA supplementation [131], highlighting the important
role of diet in brain plasticity, and AHN in particular.
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A number of studies have suggested that an enriched
environment (EE) is a promising intervention for the
improvement of AHN [136–138]. EE consists of a larger
habitat where animals are housed in groups so that social
interaction is facilitated. This environment is also charac-
terized by the presence of stimulating toys, tunnels, and
platforms. These stimuli are changed regularly in order to
promote curiosity and exploration, as well as to provide
sensorial experience, and motor and cognitive stimulation
to the animals. With regard to AHN, a study by Leal-
Galicia et al. showed increased proliferation, survival, and
differentiation of new neurons in the DG of rats submitted
to EE, as well as reduced anxiety in several behavioral tests
accompanied by higher rates of BrdU positive-cells in the
hippocampus of animals with a reduced anxiety response
[139]. In accordance with these findings, several studies have
found an improvement in neuroplasticity accompanied by
reduced anxiety in rodents subjected to EE paradigm [140–
142]. However, findings suggest that the duration of exposure
to an EE seems to influence anxiety-like behaviors. For
example, reduced anxiety in the EPM was observed in mice
exposed to an EE for 3weeks, but not in the group exposed for
24 hours, 1 week or in animals subjected to more prolonged
periods of exposure, such as five weeks [143]. However, not
all these interventional studies were undertaken with female
rodents. This highlights the need for future investigations
into the effects of these potential interventions on reducing
anxiety-like behavior in this population both in AHN-
dependent and independent manners.
Another possible category of intervention could be
hormonal therapy. E2-based therapies have been used for
many years to treat physiological symptoms associated with
menopause such as hot flushes, sweating, genital dryness, and
mental symptoms, such as cognitive deficits and increased
anxiety [20]. Several studies in menopausal women have
shown that E2 replacement therapy attenuates the loss of
cognitive performance associated with the end of the repro-
ductive cycle [9]. Women who received E2 after menopause
demonstrate verbal improvement, and improvement in short
and long-term memory, as well as logical reasoning, com-
pared to controls [144, 145]. In animal models, it has been
shown that cognitive deficits related to reduction of circulat-
ing E2 levels after menopause coincided with the reduction
of cell proliferation in the hippocampus [83]. On the other
hand, increasing levels of estradiol have been suggested to
improve neurogenesis and cognitive aspects. As shown by
a study by Frye et al., E2 administration to mice reverses
the cognitive deficits caused by aging, significantly improving
spatial learning performance and reference memory in the
water maze task [146].
However, the limitations of hormone replacement ther-
apies due to their proliferative effects on breast and uterus
curbed the enthusiasm of the use of E2 as treatments for
anxiety disorders [147].Moreover, not all individuals respond
favorably to E2. Some women with anxiety disorders report
less anxiety when E2 levels are low and/or relatively stable,
which suggests that some individuals may be more sensitive
than others to E2 [9, 148]. For these individuals, other
strategies such as diet based on phytoestrogens, compounds
present, for example, in soy extract with weak estrogenic
or antiestrogenic activity, might be useful considering their
neuroprotective effect, and their ability to increase the pro-
duction of new cells in the hippocampus [84]. Another
phytoestrogen, 𝛼-zearalanol (𝛼-ZAL), has been used as a safe
alternative for estrogen, due to reduced side effects on the
uterus and breast. Studies showed that both 𝛼-ZAL and 17𝛽-
E2 improved neurogenesis and learning and memory deficits
[149].
Data from a recent study, though, showed that treatment
with 10b, 17b-dihydroxyestra-1,4-dien-3-one (DHED) was
effective in reducing symptoms associated with estrogen
deficits in the brain and in promoting neuroprotective effects
in rats [150]. These are promising findings, considering that
DHED is a small-molecule bioprecursor prodrug which is
converted to 17b-estradiol in the brain but remains inactive
in the rest of the body. This, therefore, prevents the adverse
side effects normally found in the periphery and for which
reason estrogen replacement therapies cannot be used safely.
Besides, as previously discussed, it could be hypothesized
that cases unresponsive to E2 could still benefit from other
practices such as those related to diet, exercise, and a
stimulating environment. Novel studies are, however, still
needed to assess their efficacy in terms of onset, duration, and
synergistic effects with other interventions and conditions in
humans, with a special focus here on the female population.
4. Discussion
Animal models can help to elucidate some aspects of neu-
ropsychiatric disorders, but their establishment implies some
important principles. Behavioral models can be appropriate
for one sex and inappropriate for another, and generaliza-
tions on the findings in one sex to another seem to be a
biased process at best. Therefore, caution is needed when
interpreting data, as it may be possible that certain behavioral
paradigms and interventions are not interchangeable inmales
and females [5]. In addition to behavioral differences, there
are outstanding physiological differences between genders,
as indicated throughout the paper. The reproductive process
results in important functional changes in the female brain,
mainly due to gonadal hormones. AHN, for example, is
regulated in females and males by both gonadal and adrenal
hormones, but are sex- and experience-dependent [73]. This
shows that it cannot be affirmed that males and females
have each a certain established neurogenic profile, as this
changes in accordance with a number of variables. Moreover,
results of behavioral or physiological analysis in females
depend on the stage of the estrous cycle, that is, the hormone
levels that are circulating at that moment [83, 89]. Finally,
there is a very small number of studies in the literature
assessing gender differences in behavioral tests of anxiety.
Therefore, the hypothesis raised in this review will only be
fully answered by future studies on the possible mechanisms
underlying the gender gap with regard to stress or threat
responses, as well as using AHN markers as one of their
neurobiological readouts. These will be an invaluable source
to help us better understand the differential vulnerability for
mood and anxiety disorders between men and women [7].
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Clinical studies showed that due to the sudden drop of
estradiol levels that occurs during pregnancy, postpartum
women have a higher reactivity of the HPA axis to stressors
[27, 151]. Furthermore, estradiol is pointed to modulate
neurotransmission, synaptic plasticity, and neurogenesis [75,
152], besides cognitive functions and emotional responses
through the hippocampus, a structure known as one of
the key regions of the so-called emotional brain due to its
role in modulating anxiety states [12, 153]. There is growing
evidence showing that deficits in neurogenesis are related to
increased anxiety-like behavior [12, 154–157]; on that account,
investigating the mechanisms of action and effects of E2 on
the modulation of AHN and anxiety disorders has become
a goal of potentially great importance and clinical impact.
In recent years, a significant increase in life expectancy of
women has been observed; however, the age of onset of
menopause has remained relatively constant, resulting in a
larger portion of life, about one-third, where women live
with low endogenous levels of E2. It is therefore likely that
more women make use of therapies based on E2 to relieve
symptoms of menopause, necessitating an intensification of
research into the possible benefits and risks of hormone
replacement therapy [20, 32, 158].
Functional neuroimaging techniques also appear to be
a promising tool to reveal the neural mechanisms underly-
ing anxiety disorders, leading to the development of more
effective therapeutic options, as they can help us understand
how new pharmacological treatment options may work and
predict if the patient is likely to respond to a particular
intervention or not [159]. Despite the extensive amount of
research in animals, little is known about the mechanisms
of neurogenesis in the adult human brain, which is limited
by postmortem histological studies [160, 161].Thus, the future
development of more sensitive and specific techniques of
molecular neuroimaging for the investigation of humanAHN
is of great importance, as they hold unprecedented potential
for the design of more effective treatment, with less side
effects and improved life expectancy and quality of life.
5. Conclusion
Consistent evidence in the literature points to important
differences betweenmales and females with regard to anxious
behavior and a number of biological mechanisms, including
AHN, with different interventions bringing both sex- and
age-dependent differential regulation of the ability of the hip-
pocampus to generate newly functional neurons throughout
life. As a whole, studies with animal models support the
overall idea that increased levels of AHN are associated with
decreased levels of cognitive deficits and anxiety. Therefore,
interventions that are able to promote AHN are hypothesized
as potentially effective to improve anxiety-like behavior,
although further testing in female rodents and in the human
population at different ages is still needed.
Of special note, disrupted levels of estrogen atmenopause
may contribute to the development of pathological anxiety. In
addition, with increasing life expectancy, it is likely that more
women will make use of estrogen-based therapies to relieve
symptoms of menopause, making it necessary that research
in females be undertaken into the possible benefits and risks
of hormone replacement therapy, as well as on interventions
that may enhance AHN and alleviate symptoms of anxiety.
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